(RTTNews) - Today's Daily Dose brings you news about Akebia's phase II trial of kidney disease drug; Ascendis' progress in hypoparathyroidism trial; Avinger's receipt of CE Mark; disappointing results ...
Dallas, TX, March 21, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in drug testing using hair analysis, is proud to announce its recognition as one of the Top 10 ...
DALLAS, June 21, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing for drugs of abuse, proudly presents its inaugural Insights Report. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results